Cost effectiveness of withdrawal of fall-risk-increasing drugs in geriatric outpatients

Drugs and Aging

Volumn 25, Issue 6, 2008, Pages 521-529

  Van Der Velde, Nathalie ^a   Meerding, Willen Jan ^a   Looman, Caspar W ^a   Pols, Huibert A P ^a   Van Der Cammen, Tischa J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness; Drug withdrawal; Elderly

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIVERTIGO AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; EYE DROPS; HYPNOTIC AGENT; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG WITHDRAWAL; FALL RISK; FALLING; FEMALE; FOLLOW UP; GERIATRIC CARE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RISK REDUCTION; TELECONSULTATION;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; COHORT STUDIES; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; MALE; OUTPATIENTS; PHARMACEUTICAL PREPARATIONS;

EID: 44949125465     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825060-00005     Document Type: Article

References (28)

1. Haumschild MJ, Karfonta TL, Haumschild MS, et al. Clinical and economic outcomes of a fall-focused pharmaceutical intervention program. Am J Health Syst Pharm 2003; 60: 1029-32
2. Carroll NV, Slattum PW, Cox FM. The cost of falls among the community-dwelling elderly. J Manag Care Pharm 2005; 11: 307-16
3. Scuffham PA, Chaplin S, Legood R. Incidence and costs of unintentional falls in older people in the United Kingdom. J Epidemiol Community Health 2003; 57: 740-4
4. Stephens JA, Corso PS, Finkelstein EA, et al. The costs of fatal and nonfatal falls among older adults. Inj Prev 2006; 12: 290-5
5. Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med 1989; 320: 1055-9
6. Tinetti M, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994; 331: 821-7
7. Gillespie L. Preventing falls in elderly people. BMJ 2004; 328: 653-4
8. Kannus P, Parkkari J, Koskinen S, et al. Fall-induced injuries and deaths among older adults. JAMA 1999; 281: 1895-9
9. Van Weel C, Vermeulen H, van den Bosch W. Falls: a community care perspective. Lancet 1995; 345: 1549-51
10. Rivera FP, Grossman DC, Cummings P. Injury prevention. N Engl J Med 1997; 337: 543-7
11. Kannus P, Niemi S, Parkkari J, et al. Why is the age-standardized incidence of low-trauma fractures rising in many elderly populations? J Bone Miner Res 2002; 17: 1363-7
12. Kannus P, Siev̈anen H, Palvanen M, et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005; 26: 1885-93
13. Campbell AJ, Robertson AC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized controlled trial. J Am Geriatr Soc 1999; 47: 850-3
14. Van der Velde N, Stricker BHCh, Pols HAP, et al. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharm 2007; 63: 232-7
15. Stel VS, Smit JH, Pluijm SMF, et al. Consequences of falling in older men and women and risk factors for health service use and functional decline. Age Ageing 2004; 33: 58-65
16. Meerding WJ, Mulder S, Van Beeck AF. Incidence and costs of injuries in the Netherlands. Eur J Pub Health 2006; 16: 272-8
17. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98
18. Chang JT, Morton SC, Rubenstein LZ, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. J Clin Epidemiol 2000; 53: 1222-9
19. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systemic review and meta-analysis. I: psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-9
20. Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002; 50: 1629-37
21. Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339: 875-82
22. Chang JT, Morton SC, Rubenstein LZ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 2004; 328: 680
23. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systemic review and meta-analysis. II: cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 40-50
24. Stel VS, Pluijm SMF, Deeg DJH, et al. A classification tree for predicting recurrent falling in community-dwelling older persons. J Am Geriatr Soc 2003; 51: 1356-64
25. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002; 20: 443-54
26. The Health Care Insurance Board. Pharmacotherapeutical compass [College voor Zorgverzekeringen. Farmacotherpateutisch kompas]. Utrecht: Roto Smeets Utrecht, 2005
27. Efron B, Tibshirani R. An introduction to the bootstrap. New York: Chapman and Hall, 1993
28. Alsop K, MacMahon M. Withdrawing cardiovascular medications at a syncope clinic. Postgrad Med J 2001; 77: 403-5